Professor in the Departments of Microbiology & Immunology and Pathology, Dr. Nisha J Garg holds the Robert E. Shope, MD Distinguished Chair in Global Health, and serves as the UTMB Associate Research Officer in Basic Sciences and Associate Director of the Institute for Human Infections and Immunity. She is a world renowned expert in cardiomyopathy of infectious etiology and has conducted pioneering research on understanding the pathogenesis of Chagas disease and on strategies for early diagnosis and treatment of heart disease. Dr. Garg serves on external review committees of the NIH, American Heart Association, and other international funding agencies, as well as editorial boards of numerous journals, including American Journal of Pathology, American Journal of Cardiovascular Disease, NPJ Vaccines, and Infection and Immunity. She has recently completed the The Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM®) program. She served as Senior Scientific Advisor to the U.S. Agency for International Development, engaged in implementing the Neglected Tropical Diseases Initiative in Latin America. Dr. Garg has made substantial contributions as an investigator, educator, and mentor. She has conducted pioneering research on understanding the pathogenesis of chagasic disease of the heart that afflict millions of people, and developing unique strategies for early diagnosis and prevention of cardiac disease. Dr. Garg’s research program has been consistently funded by extramural sources. She currently has NIH R01 research grant and is a collaborator on a number of NIH small grants. She has authored or co-authored >75 papers in peer-reviewed journals, including the J Am Coll Cardiol, Mol Cell Proteomics, Am J Pathol, Internatl J Cardiol, and J Immunol. As a mentor, Dr. Garg has an outstanding track record promoting the scientific careers of junior faculty. As Chair of the ARM, she and her collaborators continue to enhance mentoring and team research by helping investigators develop skills, setting standards for excellence, promoting innovation, and recognizing and rewarding achievement.
Pietro Mastroeni Current position. Reader in Infection and Immunity, University of Cambridge. Education. 1990. Doctor of Medicine and Surgery at the University of Messina, Italy. 1991-94. Doctor of Philosophy, Department of Pathology and Darwin College, University of Cambridge. Professional history. 1992-96. Ricercatore Universitario in Malattie Infettive (tenured Lectureship in Infectious Diseases), University of Messina, Italy. 1997. Research Associate at the University of Newcastle, Department of Microbiology, The Medical School, Newcastle upon Tyne, UK. 1997-1999. Research Fellow, Department of Biochemistry, Imperial College of Science, Technology and Medicine, University of London, UK. 1999-2004. University Lecturer in Microbiology, Department of Veterinary Medicine, University of Cambridge. 2004-2008. University Senior Lecturer in Microbiology, Department of Veterinary Medicine, University of Cambridge. Reviewing and Editorial activities Member of the Editorial Board of Microbes and Infection, The Scientific World Journal and The Canadian Journal of Infectious Diseases and Medical Microbiology. Reviewing papers for: Nature Medicine, Nature Biotechnology, Proceedings of the National Academy of Science (PNAS), Journal of Experimental Medicine, Journal of Infectious Diseases, Cell, Host and Microbe, European Journal of Immunology, Cellular Microbiology, Journal of Antimicrobial Chemotherapy, PLoS Pathogens, PLoS One, Immunology, Infection and Immunity, FEMS Immunology and Medical Microbiology, Microbiology, BioDrugs, Clinical and Experimental Immunology, Molecular Microbiology, Trends in Microbiology, Canadian Journal of Microbiology, International Immunopharmacology, Microbes and Infection, Expert Reviews in Molecular Medicine, Veterinary Research, Immunology and Cell Biology, Veterinary pathology, The International Journal of Bacteriology, Frontiers in Immunology, Journal of Medicine and Medical Science Research, Future Microbiology, mBio. Reviewing Grants for Biotechnology and Biological Sciences Research Council (BBSRC), The Wellcome Trust, Medical Research Council (MRC), European Research Council, Horserace Betting Levy Board (HBLB), World Health Organisation (WHO), Royal Society, Medical Research Scotland, Grant Agency of the Czech Republic, Swiss National Science Foundation, Foundation for Science and Technology of Portugal (FCT), Action Medical Research and British Society for Antimicrobial Chemotherapy, National Science Center, Poland. Research interests. My research has focused on the interplay between bacterial pathogenesis and the immune system as the foundation for vaccine development and improved antibiotic therapy. I am interested in understanding how inflammation and immunity control bacterial infections and to study the genes/mechanisms that allow bacteria to evade killing by antibodies and phagocytes. I am also interested in the interaction between cellular and humoral adaptive immunity and in receptors and soluble mediators used by the immune system to control bacterial infections. I have been involved in the discovery and/or functional characterization of many bacterial virulence and/or immune-evasion genes as targets for live attenuated vaccine candidates. I have also combined traditional tools with forefront genome-wide approaches to understand bacterial adaptation to the host immune response in vivo and to discover vaccine candidates that are safer in immune-compromised individuals. My research has pioneered and used innovative multidisciplinary approaches, which combine immunology, microscopy, molecularly tagged microbial subpopulations and mathematical modeling, to study bacterial infection dynamics in vivo. This allowed my research group to unravel the impact of immunity, vaccination and antibiotics on pathogen behaviour at the single cell level. These approaches, are revolutionizing the study of many bacterial infections in vivo, are enabling scientists to move away from compartmentalized approaches and are yielding a global understanding of infection biology. I have also been involved in other research areas within infection, including the interplay between bacteria, autoimmune diseases and cancer
(micro)biological and chemical threats and medical
CEO of Nanorx INC has a Ph.D. in Organic Chemistry from Oregon State University(1979) and an M.S in Chemistry(1972) from I.I.T Mumbai, India.He has worked on drug discovery for over 25 years at Columbia University, Max-Planck Institute, Germany, Ciba-Geigy (now Novartis) and Boehringer Ingelheim. He has over 15 US and International patents and another 15 pending patent applications
INFECTIOUS DISEASES AND IMMUNITY
His research interests are interdisciplinary in nature and include Chaotic Dynamics of real world situations, Differential equations, Population dynamics for marine and terrestrial ecosystems, Disease Dynamics (spread of Bird flu and recent epidemic of Ebola virus in West Africa), Reaction-diffusion modeling, Neural modeling, Environmental modeling and Dynamical systems theory.
Professor in the Department of Microbiology at Federal University of Alagoas (UFAL), Dr Fernanda C. de A. Maranhão is geneticist and received her PhD at the University of São Paulo after experience in gene expression of pathogen fungi (USP, 2004-2008), com postdoctoral experience in Medical Microbiology at Federal University of Ceará (UFC, 2009-2010). She is the coordinator of the Laboratory of Clinical Microbiology (LMC/UFAL), leading research on the molecular identification of Staphylococcus aureus, Candida species and Pseudomonas aeruginosa and genotyping of Cryptococcus complex and dermatophytes, accompanying healthcare-associated infections and patients from the main hospitals in Alagoas (mainly with autoimmune diseases) and . She also participates in research on antimicrobial resistance genes and action of bioactives as antifungal. Dr. Maranhão acts as a member of the editorial board and reviewer of the African Journal of Microbiology Research, Journal of Health and Biological Sciences, Journal of Integrative Biology, Fungal Genomics and Biology and Bioscience Magazine.
Research interest in: Infections diseases, HAIs, Molecular mechanisms of pathogenicity; and Drug resistance, Molecular diagnostic, Transcriptome of bacterial and Fungi pathogens.